Cambrex Reports Third Quarter 2017 Financial Results
November 07, 2017 06:45 ET
|
Cambrex Corporation
- Net Revenue increased 13% and EBITDA increased 29% vs. prior year quarter - - 2017 full year financial guidance reaffirmed - - Conference call at 8:30 a.m. ET on November 7, 2017 - EAST...
Cambrex to Present at the Stephens Fall Investment Conference
November 03, 2017 12:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation
November 03, 2017 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Announce Third Quarter 2017 Financial Results on November 7, 2017
October 31, 2017 10:45 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Adds Large Scale Manufacturing Capacity at Its Charles City, Iowa Facility
October 23, 2017 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Invests in Generic API Development and Manufacturing Capabilities at Its Milan Site
October 12, 2017 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Opens Large Scale API Manufacturing Facility and Invests in Supporting Waste Water Treatment Plant at Its Karlskoga, Sweden Site
September 26, 2017 07:30 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
September 18, 2017 10:15 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex to Present at Upcoming Investor Conferences in September
August 30, 2017 09:15 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...
Cambrex Invests in New Analytical Development and Method Validation Laboratory at Its High Point, NC Facility
August 30, 2017 09:10 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...